Author: Business Wire

Definium Therapeutics Announces New Employee Inducement Grants

February 2, 2026
Palantir Reports Q4 2025 U.S. Comm Revenue Growth of 137% Y/Y and Revenue Growth of 70% Y/Y; Issues FY 2026 Revenue Guidance of 61% Y/Y and U.S. Comm Revenue Guidance of 115% Y/Y, Crushing Consensus Expectations

February 2, 2026

1 … 4,701 4,702 4,703

Definium Therapeutics Announces New Employee Inducement Grants